EFFICACY AMONG NORTH AMERICAN AND EUROPEAN HCV GENOTYPE-1 TREATMENT-NAIVE AND PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

被引：2

作者：

Marcellin, P. ^{[1
,2
]}

Vierling, J. M. ^{[3
]}

Alric, L. ^{[4
,5
]}

Pirisi, M. ^{[6
]}

Tran, A. ^{[7
]}

Albrecht, J. K. ^{[8
]}

Brass, C. A. ^{[8
]}

Boparai, N. ^{[8
]}

Sniukiene, V. ^{[8
]}

Burroughs, M. ^{[8
]}

机构：

[1] Univ Paris 07, Paris, France

[2] Hop Beaujon, Clichy, France

[3] Baylor Coll Med, Houston, TX 77030 USA

[4] Univ Toulouse 3, F-31062 Toulouse, France

[5] Purpan Hosp, Toulouse, France

[6] Univ Eastern Piedmont Amedeo Avogadro, Novara, Italy

[7] Archet Hosp, Nice, France

[8] Merck, Whitehouse Stn, NJ USA

来源：

JOURNAL OF HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

10.1016/S0168-8278(11)60454-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

452

引用

页码：S184 / S184

页数：1

共 50 条

[1] Efficacy among North American and European HCV genotype-1 treatment-naive and previous non-responders and relapsers to peginterferon/ribavirin when treated with boceprevir plus peginterferon alfa-2b/ribavirin
Bognar, F.
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 97 - 98
[2] Efficacy Among North American and European HCV Genotype-1 Treatment-NaiVE and Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin
Marcellin, Patrick
Vierling, John M.
Alric, Laurent
Pirisi, Mario
Tran, Albert
Albrecht, Janice K.
Brass, Clifford A.
Boparai, Navdeep
Sniukiene, Vilma
Burroughs, Margaret
[J]. GASTROENTEROLOGY, 2011, 140 (05) : S945 - S945
[3] Predictors of sustained virologic response among genotype 1 previous non-responders and relapsers to peginterferon/ribavirin when re-treated with boceprevir plus peginterferon alfa-2b/ribavirin
Bognar, F.
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 95 - 95
[4] Predictors of Sustained Virologic Response Among Genotype 1 Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin
Zeuzem, Stefan
Vierling, John M.
Esteban, Rafael
Gibas, Alexandra L.
Pol, Stanislas
Boparai, Navdeep
Burroughs, Margaret
Brass, Clifford A.
Albrecht, Janice K.
Poordad, Fred
[J]. GASTROENTEROLOGY, 2011, 140 (05) : S908 - S909
[5] PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
Zeuzem, S.
Vierling, J. M.
Esteban, R.
Gibas, A. L.
Pol, S.
Boparai, N.
Burroughs, M.
Brass, C. A.
Albrecht, J. K.
Poordad, F.
[J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S198 - S199
[6] Predictors of sustained virologic response among genotype 1 previous non-responders and relapsers to peginterferon/ribavirin when re-treated with boceprevir plus peginterferon alfa-2b/ribavirin
Bognar, F.
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 20 - 20
[7] OVERALL SAFETY PROFILE OF BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN IN GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN
Flamm, Steven L.
Lawitz, Eric
Jacobson, Ira M.
Bourliere, Marc
Hezode, Christophe
Vierling, John M.
Niederau, Claus
Sherman, Morris
Bacon, Bruce R.
Pedicone, Lisa
Goteti, Venkata S.
Burroughs, Margaret
Brass, Clifford A.
Albrecht, Janice K.
Poordad, F. Fred
[J]. HEPATOLOGY, 2011, 54 : 838A - 838A
[8] HCV RESPOND-2 FINAL RESULTS: HIGH SUSTAINED VIROLOGIC RESPONSE AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR PLUS PEGINTRON (PEGINTERFERON ALFA-2B)/RIBAVIRIN
Bacon, Bruce R.
Gordon, Stuart C.
Lawitz, Eric
Marcellin, Patrick
Vierling, John M.
Zeuzem, Stefan
Poordad, Fred
Boparai, Navdeep
Burroughs, Margaret
Brass, Clifford A.
Albrecht, Janice K.
Esteban, Rafael
[J]. HEPATOLOGY, 2010, 52 (04) : 430A - 430A
[9] HIGH SUSTAINED VIROLOGIC RESPONSE (SVR) AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN
Flamm, S.
Lawitz, E.
Jacobson, I.
Rubin, R.
Bourliere, M.
Hezode, C.
Vierling, J.
Niederau, C.
Sherman, M.
Goteti, V.
Vilchez, R.
Brass, C.
Albrecht, J.
Poordad, F.
[J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S541 - S542
[10] High Sustained Virologic Response (SVR) Among Genotype I Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated with Boceprevir (BOC) Plus Peginterferon Alfa-2A/Ribavirin
Flamm, Steven L.
Lawitz, Eric J.
Jacobson, Ira M.
Rubin, Raymond A.
Bourliere, Marc
Hezode, C.
Vierling, J.
Niederau, Claus
Sherman, Morris
Goteti, Venkata S.
Vilchez, Regis A.
Brass, Clifford A.
Albrecht, Janice K.
Poordad, Fred
[J]. GASTROENTEROLOGY, 2011, 140 (05) : S145 - S145

← 1 2 3 4 5 →